✦ LIBER ✦

Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2–10 years: A Phase II/III double-blind randomized controlled trial

✍ Scribed by Siddhivinayak Hirve; Ashish Bavdekar; Anand Pandit; Sanjay Juvekar; Malini Patil; Marie-Pierre Preziosi; Yuxiao Tang; Elisa Marchetti; Lionel Martellet; Helen Findlow; Cheryl Elie; Varsha Parulekar; Brian Plikaytis; Ray Borrow; George Carlone; Prasad S. Kulkarni; Akshay Goel; Karupothula Suresh; Suresh Beri; Subhash Kapre; Suresh Jadhav; Jean-Marie Preaud; Simonetta Viviani; F. Marc LaForce

Book ID: 118503242
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 311 KB
Volume: 30
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2012.08.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a quadrival

Safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-DT): Amulticenter, open-label, non-randomized, phase III clinical trial

✍ Yadav, Sangeeta; Manglani, M. V.; Ashwath Narayan, D. H.; Sharma, S.; Ravish, H. 📂 Article 📅 2014 🏛 Indian Academy of Pediatrics 🌐 English ⚖ 483 KB

Safety and immunogenicity of a tetravale

Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2–11 years in Malaysia: A randomized, placebo-controlled, Phase III study

✍ HSS, Amar-Singh; Koh, Mia-Tuang; Tan, Kah Kee; Chan, Lee Gaik; Zhou, Lynn; Bouck 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 704 KB

A randomized, double-blind trial to eval

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years

✍ T.F. Schwarz; J. Flamaing; H.C. Rümke; J. Penzes; C. Juergens; A. Wenz; D. Jayaw 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Comparison of the safety and immunogenic

Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2–10 years of age

✍ Scott A. Halperin; Anil Gupta; Robert Jeanfreau; Nicola P. Klein; Keith Reisinge 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 339 KB

A double-blind, randomized phase II tria

A double-blind, randomized phase II trial of the safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults

✍ Shelly A. McNeil; Scott A. Halperin; Joanne M. Langley; Bruce Smith; Darlene M. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Safety and immunogenicity of a glycoprot

Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10–17 years of age: Results from a randomised, controlled, double-blind trial

✍ xxx, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 714 KB